Assignee
SHENZHEN ANTIV PHARMA CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
5 records- 0175US2024366617A1Novel crystalline forms of a nucleoside compound and salts thereofSHENZHEN ANTIV PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0267US2025049832A1Crystal form of nucleoside compoundSHENZHEN ANTIV PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0364US2025032526A1Composition, method for preparing same, and use thereofSHENZHEN ANTIV PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0463US2025339377A1Pharmaceutical composition of nucleoside-derived compound, preparation method therefor, and use thereofSHENZHEN ANTIV PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0559US2025066366A1Crystal form of isobutyrate nucleoside compound, and preparation methodSHENZHEN ANTIV PHARMA CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN ANTIV PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →